ACE2 and viral infectious disease: Both ACE2-WT and ACE2-QMP effectively blocked viral infection with a half-maximal inhibitory concentration (IC50) of 15–20 nM, which was about 2- to 4-fold higher than that of unfused ACE2 (7.9 nM) (Figs. 2F and S2; Table S3).